Last update :
16/06/2024
Thrombolytic   Reteplase  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Rapilysine Austria, Belgium, Denmark, Italy, Netherlands, Portugal, Spain, Sweden
Retavase United States of America
References   Injection   References : Reteplase  
Type Publication
1713 Journal Trissel LA, Saenz CA.
Compatibility screening of bivalirudin during simulated Y-site administration with other drugs.
Int J Pharm Compound 2002 ; 6: 311-315.
2212 Manufacturer Reteplase (Rapilysin®) - Summary of Product Characteristics
Actavis UK Ltd 2015
3539 Manufacturer Bivalirudin (Angiox®) - Summary of Product Characteristics.
The Medecines Company 2013
3540 Manufacturer Heparin sodium - Summary of Product Characteristics.
Wockhardt 2010

  Mentions Légales